2 Stocks moving on opposite sides of the ASX ladder – DCC, ALX

Digitalx Ltd received funding commitment from First Growth Funds Limited

ICO platform development and funding commitment: Digitalx Ltd.’s (ASX: DCC) stock fell 1% on September 18, 2018 after the company’s Initial Coin Offering (ICO) issuance platform, FutureICO, which is being developed in a joint venture has received a funding commitment from First Growth Funds Limited. The platform provides a seamless way for ICO applicants and ICO issuers to interact under a compliant framework. FutureICO leverages the key expertise of the three groups, namely Blockchain development, cryptoasset security and knowledge of cryptoasset compliance. Moreover, FutureICO and the joint venture parties have signed a binding terms sheet with First Growth, according to which First Growth will subscribe for 25% of the equity in FutureICO, to the value of US$285,000. First Growth will have the right to appoint a nominee to the board of FutureICO. After the subscription, the capital structure of FutureICO will be approximately DigitalX (34%), Blockchain Global Limited (34%), Big Start Pty Ltd (7%) and First Growth (25%). Meanwhile, DCC stock has risen 11.11% in three months as on September 17, 2018  and is trading at a P/E of 12.05x. The stock has been lately impacted by volatile movement in cryptocurrency space. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

Atlas Arteria Announces Dividend for Second-half of 2018

Declared the Dividend: Atlas Arteria Group (ASX: ALX), earlier known as Macquarie Atlas Roads (MQA), saw its stock price rise by about 0.5% on September 18, 2018 after the company for the second-half of 2018 announced a distribution of 12.0 Australian cents per stapled security (cps). The distribution will be paid in full by ALX and the distribution includes a capital return of 11.3 cps and an unfranked dividend of 0.7 cps. Meanwhile, ALX stock has risen 8.11% in three months as on September 17, 2018.

12345678.png Dividend for Second Half 2018 (Source: Company Reports)

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report